2015 Emerging Transfusion Diagnostic Technologies, and Strategic Profiles of Leading Suppliers

July 2015 | 114 pages | ID: 28B7B406179EN
Venture Planning Group

Abstracts

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 114 pages

Contents

CURRENT AND EMERGING TECHNOLOGIES

MOLECULAR DIAGNOSTICS

a. Overview
b. NAT

MONOCLONAL AND POLYCLONAL ANTIBODIES IMMUNOASSAYS

a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  EMIT
  Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
  Microtitration Plates
  IT and Automation
  Lasers
  Robotics
  Synthetic Red Cell Substitutes

Genetically Engineered Blood Components

a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
  Blood Preservation
  Autologous Blood Transfusion/Freezing

COMPETITIVE PROFILES

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Gen-Probe
Grifols
Immucor
Innogenetics
Ortho-Clinical Diagnostics
Orchid CellMark
Novartis Diagnostics
Proteome Sciences
Roche
Siemens
Tecan